Cited by 216Blood Coagulation and Thrombosis MechanismsAdipokines, Inflammation, and Metabolic DiseasesCardiovascular Disease and Adiposity

New insights into the role of adipose tissue in thrombosis

Vilahur, Gemma, Ben-Aicha, Soumaya, Badimon, Lina·2017·Cardiovascular Research

Abstract

Central obesity is independently associated with an elevated risk of cardiovascular disease, particularly thrombotic complications. Increasing data supports a link between excess body weight and the risk to suffer acute myocardial infarction, stent thrombosis after percutaneous interventions, ischemic stroke and vein thrombosis. Experimental and in vitro data have provided insights as to the mechanisms currently presumed to increase the thrombotic risk in obese subjects. Obesity is characterized by a chronic low grade inflammation and systemic oxidative stress that eventually damage the endothelium losing its antithrombotic properties. Obesity also stimulates the expression of leptin and attenuates adiponectin release, a protective adipokine. Although the contribution of adipokines to thrombosis has been questioned, recent work has suggested that they enhance platelet activation and, although to a lesser extent, induce the coagulation cascade through tissue factor (TF) expression. Increased body weight also impairs platelet sensitivity to insulin signaling and enhances the production of bioactive isoprostanes further promoting platelet reactivity. Finally, obese subjects have shown elevated circulating levels of von Willebrand factor, TF, factor VII and VIII, and fibrinogen, favoring a mild-to-moderate hypercoagulable state, and, on the other hand, increased secretion of plasminogen activator inhibitor (PAI)-1 and thrombin activatable fibrinolysis inhibitor (TAFI) contributing to impair the fibrinolytic system. In the present review, we provide an overview of the impact of excess body weight on thrombosis. We will focus on the link between dysfunctional adipose tissue and endothelial damage, platelet reactivity, enhanced coagulation and impaired fibrinolysis; mechanisms currently recognized to increase arterial thrombotic risk in obese subjects.

Integrity signals

Registry

Crossref · 10.1093/cvr/cvx086

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Vilahur, G., Ben-Aicha, S., & Badimon, L.
Affiliations
Instituto de Salud Carlos III (ES)
Corresponding author
Vilahur, Gemma
Venue
Cardiovascular Research
Published
2017-05-03
Volume
113
Issue
9
Pages
1046-1054
ISSN
  • 0008-6363 (ISSN-L)
  • 1755-3245
OpenAlex
W2611087294
Cited by
216
References
98
Citations by year
2026: 27 · 2025: 20 · 2024: 24 · 2023: 14 · 2022: 29 · 2021: 33 · 2020: 34 · 2019: 21 · 2018: 11 · 2017: 3
FWCI
2.97
Type
journal article
Language
en
Open access
closed
Locations
  • Cardiovascular Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Sociedad Española de Cardiología
  • Ministerio de Ciencia e Innovación (SAF2016-76819-R, PNS 2015-71653-R, SAF2016-76819, PNS SAF2016-76819-R, 2015-71653)
  • Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CB16/11/00411)
  • Instituto de Salud Carlos III ([CB16/11/00411], RD16/0011/018)
Topics
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
Keywords
obesity, thrombosis, adipose tissue dysfunction, abdominal obesity, endothelial dysfunction, platelet activation, isoprostanes, leptin, adiponectin, tissue factor, hypercoagulability, fibrinolysis, von Willebrand factor, plasminogen activator inhibitor-1, thrombin-activatable fibrinolysis inhibitor, acute myocardial infarction, ischemic stroke, venous thrombosis, stent thrombosis, oxidative stress, chronic inflammation
MeSH terms
Adipose Tissue, Animals, Blood Coagulation, Blood Coagulation Factors, Blood Platelets, Endothelium, Vascular, Humans, Risk Factors, Thrombosis, Signal Transduction, Adiposity, Adipokines, Obesity, Abdominal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review